Westfield Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Buy
34,378
+28,413
+476% +$1.54M ﹤0.01% 260
2026
Q1
$374K Sell
5,965
-2,707
-31% -$217K ﹤0.01% 239
2025
Q4
$827K Buy
8,672
+1,080
+14% +$106K ﹤0.01% 228
2025
Q3
$741K Buy
7,592
+3,923
+107% +$406K ﹤0.01% 227
2025
Q2
$394K Sell
3,669
-1,356
-27% -$137K ﹤0.01% 236
2025
Q1
$507K Buy
5,025
+745
+17% +$75K ﹤0.01% 237
2024
Q4
$382K Buy
4,280
+25
+0.6% +$2.2K ﹤0.01% 231
2024
Q3
$357K Buy
+4,255
New +$335K ﹤0.01% 244
2022
Q1
Sell
-81,153
Closed -$3.45M 239
2021
Q4
$3.45M Sell
81,153
-1,921,076
-96% -$80.7M 0.02% 205
2021
Q3
$86.9M Buy
2,002,229
+162,486
+9% +$7.19M 0.52% 66
2021
Q2
$78.7M Sell
1,839,743
-1,231,876
-40% -$51.8M 0.47% 77
2021
Q1
$119M Sell
3,071,619
-393,109
-11% -$14.9M 0.74% 39
2020
Q4
$125M Buy
3,464,728
+462,115
+15% +$16.7M 0.74% 36
2020
Q3
$115M Sell
3,002,613
-97,538
-3% -$3.76M 0.74% 40
2020
Q2
$109M Buy
3,100,151
+1,165,267
+60% +$42M 0.75% 40
2020
Q1
$63.1M Sell
1,934,884
-683,750
-26% -$26.7M 0.56% 57
2019
Q4
$118M Buy
2,618,634
+647,200
+33% +$27.1M 0.84% 29
2019
Q3
$80.2M Buy
+1,971,434
New +$83.5M 0.64% 53

Other funds holding BSX

Westfield Capital Management's BSX Position: Q2 2026 in Review

Westfield Capital Management increased its Boston Scientific (BSX) stake by 476% in Q2 2026, buying an estimated $1.54M and bringing the position to 34,378 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #260.

Westfield Capital Management first reported a position in BSX in Q3 2019 and has held it in 18 quarters since. The position peaked at $125M in Q4 2020. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Westfield Capital Management held 34,378 shares of Boston Scientific worth $1.47M as of Q2 2026.
  • Westfield Capital Management bought 28,413 Boston Scientific shares in Q2 2026, an estimated $1.54M.
  • Boston Scientific made up ﹤0.01% of Westfield Capital Management's portfolio in Q2 2026, its #260 holding.
  • Westfield Capital Management first reported a position in Boston Scientific in Q3 2019 and has held it in 18 quarters since.
  • Westfield Capital Management's Boston Scientific position peaked at $125M in Q4 2020.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.